Protagonist to Host Investor Event with KOL Insights on Polycythemia Vera (PV) and the Hepcidin Mimetic Rusfertide in New York on February 6, 2025

January 29, 2025 6:15 PM

Protagonist Therapeutics, Inc. ("Protagonist" or the "Company")will host an in-person and virtual investor event on Thursday, February 6, 2025, at 10:30 AM ET in New York. To register, click here.The event will feature key opinion leader (KOL) insights from Andrew Kuykendall, MD (Moffitt Cancer Center) and Joseph Michael Scandura, MD, PhD (Weill Cornell Medicine), who will discuss the unmet medical need and current treatment landscape for...

Read more

Onco-Innovations' Private Placement Fully Subscribed

January 29, 2025 4:45 PM

VANCOUVER, BC / ACCESS Newswire / January 29, 2025 / Onco-Innovations Limited (CSE:ONCO)(Frankfurt:W1H, WKN:A3EKSZ) ("Onco" or the "Company") is pleased to announce that its non-brokered private placement (the "Private Placement") of up to 408,164 units of the Company (the "Units") at a price of $2.45 per Unit, for aggregate gross proceeds of up to $1,000,000, as announced on January 27, 2025, is fully subscribed. Closing of the Private...

Read more

Pharma-Bio Serv Announces Full Year Results

January 29, 2025 4:25 PM

Pharma-Bio Serv, Inc. ("Pharma-Bio Serv" or the "Company") (OTCQB:PBSV), a regulatory affairs, quality, compliance, project management and technology transfer support consulting firm that provides services to the pharmaceutical, biotechnology, medical device, cosmetic, food and allied products industries, today announced that revenues for the year ended October 31, 2024 were approximately $9.5 million, a decrease of approximately $7.5 million...

Read more

Pharma-Bio Serv Announces Special Dividend

January 29, 2025 4:15 PM

Pharma-Bio Serv, Inc. ("Pharma-Bio Serv" or the "Company") (OTCQB:PBSV), a regulatory affairs, quality, compliance, project management and technology transfer support consulting firm that provides services to the pharmaceutical, biotechnology, medical device, cosmetic, food and allied products industries, today announced that the Board of Directors approved a Special Dividend of $0.075 per share for shareholders. The Special Dividend will be...

Read more

Dermata to Present on BioPub on January 31, 2025

January 29, 2025 4:05 PM

- Dermata's Chief Executive Officer and Chief Development Officer will provide a corporate update and answer live questions from the biotech investment community -SAN DIEGO, CA / ACCESS Newswire / January 29, 2025 / Dermata Therapeutics, Inc. (NASDAQ:DRMA)(NASDAQ:DRMAW) ("Dermata" or the "Company"), a late-stage biotechnology company focusing on the treatment of medical and aesthetic skin diseases and conditions, today announced it will be...

Read more

Omni-Biotic US Introduces Caricol for Constipation, Bloating, and Indigestion, and Caricol Gastro for Heartburn Relief

January 29, 2025 2:00 PM

Omni-Biotic US is pleased to announce the expansion of its product offerings with the launch of two new digestive health solutions - Caricol and Caricol Gastro. These products are designed to address common digestive issues such as constipation, bloating, indigestion, acid reflux, and heartburn, providing effective, natural relief.Caricol offers a potent, natural solution for digestive health, utilizing organic, non-GMO papaya prepared according...

Read more

Revolutionizing Cervical Cancer Prevention: New Guidelines and Diagnostic Test Offer Personalized Care

January 29, 2025 11:10 AM

Clinicians and patients working to prevent cervical cancer now have new personalized options thanks to guidance published this month. Human papillomaviruses (HPVs) cause most cervical cancers, but different HPV types carry different risks. A new test from BD Diagnostic Systems (Onclarity HPV assay) informs clinicians about not just HPV infections but responsible HPV types. New guidelines from a national panel led by ASCCP and the National Cancer...

Read more

Curiosity Cube Teaches More Than 43,000 Students About Sustainability

January 29, 2025 11:00 AM

Celebrating its sixth annual tour, the Curiosity Cube from MilliporeSigma, the U.S. and Canada Life Science business of Merck KGaA, Darmstadt, Germany, traveled across North America and Europe during 2024 to fuel curiosity and discovery among visitors.The 2024 tour brought a new look, to the Curiosity Cube's exterior and new lessons focused on sustainability. With a new look and lessons, the goal of the Curiosity Cube remained the same: enhance...

Read more

IntusCare Celebrates Milestone Year Building Momentum for 2025

January 29, 2025 10:30 AM

IntusCare, a technology leader in the PACE market, celebrated a transformative year in its offerings for PACE (Programs of All-Inclusive Care for the Elderly), underscoring its commitment to supporting value-based care (VBC) models that serve complex senior populations. The company looks to build on the significant momentum in 2025.IntusCare starts the year with additional funding, having recently announced the company raised $11.5 million in a...

Read more

Centre for Neuro Skills Earns Accreditation in Applied Behavioral Analysis and Training at Three of its Locations

January 29, 2025 9:55 AM

Centre for Neuro Skills (CNS), a leader in traumatic brain injury and stroke rehabilitation services, has been accredited by the Behavioral Health Center of Excellence (BHCOE) for demonstrating a commitment to the standards of excellence for applied behavior analysis services. The BHCOE Accreditation® distinguishes applied behavior analysis (ABA) therapy providers that demonstrate continuous improvement in applied behavior analysis and...

Read more

Ambience Healthcare Joins athenahealth's Marketplace Program to Support Clinicians with AI-assisted Documentation, Point of Care CDI & Coding, and Care Coordination

January 29, 2025 9:05 AM

Ambience Healthcare, the leading enterprise AI platform for documentation, CDI & coding, and care coordination, today announced an agreement with athenahealth, Inc through the company's Marketplace program. As part of the athenahealth® Marketplace, Ambience's AI technology, which recently received a 97.7% Spotlight Report score from KLAS Research in the Ambient AI category*, is now available to athenahealth's growing network of healthcare...

Read more

Transforming Healthcare Imaging in New Jersey: Englewood Health Selects AGFA HealthCare's Cloud Solution

January 29, 2025 9:01 AM

Englewood Health has signed a contract with AGFA HealthCare, a world leader in Enterprise Imaging, to bring AGFA HealthCare's Enterprise Imaging Cloud solution to one of New Jersey's leading healthcare systems. With the implementation underway, Englewood Health's acute care hospital and network of physician practices, urgent care centers, and imaging facilities will soon gain access to a robust, fully managed software-as-a-service (SaaS)...

Read more

Sidney S. Simmons III Joins ACU-Serve as Executive Vice President of Sales

January 29, 2025 9:00 AM

ACU-Serve, a leader in healthcare revenue cycle optimization, is excited to announce the appointment of Sidney S. Simmons III (Sid) as its new Executive Vice President of Sales. Based in Jacksonville, Florida, Sid brings a wealth of experience and a proven track record in driving sales growth and fostering industry-leading teams.Sid joins ACU-Serve at an exciting time, as the company builds on its strong momentum with a steady flow of new...

Read more

Aviva Aesthetics Partners with Renew MedSpa, Expanding Footprint to the Midwest

January 29, 2025 9:00 AM

CHICAGO, IL & EAGAN, MN / ACCESS Newswire / January 29, 2025 / Aviva Aesthetics, the only entrepreneur-owned and led medical aesthetics platform, is excited to announce its partnership with Renew MedSpa, a leading medical spa based in Eagan, Minnesota.Owned and operated by Julie Davis, Renew MedSpa has been a trusted provider of advanced aesthetic treatments for five years. With extensive certifications and years of hands-on experience in...

Read more

Jaguar Health Supports Evaluation of FDA-Approved Crofelemer to Address GI Side Effects of GLP-1 and Other Weight Loss Therapies: Files Patent Application with USPTO

January 29, 2025 8:30 AM

SAN FRANCISCO, CA / ACCESS Newswire / January 29, 2025 / Jaguar Health, Inc. (NASDAQ:JAGX) (Jaguar) family company Napo Pharmaceuticals (Napo) today announced Napo's filing of a broad defining provisional patent application with the U.S. Patent and Trademark Office (USPTO) for crofelemer, Jaguar's novel plant-based FDA-approved gastrointestinal normalizing prescription drug, to mitigate the gastrointestinal side effects associated with...

Read more

Justera Signs LOI to Acquire Crypto Company Babbage Mining Co.

January 29, 2025 7:30 AM

Justera Health Ltd. (CSE:VTAL)(OTC PINK:SCRSF) ("Justera" or the "Company") is pleased to announce that it has signed a non-binding LOI to acquire 100% of Babbage Mining Co. ("Babbage Mining"), on January 28, 2025 (the "Transaction").The terms of the proposed transaction include the issuance of 12,000,000 common shares of the Company ("Consideration Share") at a deemed value of $0.02 per Share, with a 1% royalty, subject to applicable laws and...

Read more

Moderna to Report Fourth Quarter and Full Year 2024 Financial Results on Friday, February 14, 2025

January 29, 2025 7:00 AM

Moderna, Inc. (NASDAQ:MRNA) today announced that it will host a live conference call and webcast at 8:00 a.m. ET on Friday, February 14, 2025 to report its fourth quarter and full year 2024 financial results, and provide a corporate update.A live webcast of the call will be available under "Events and Presentations" in the Investors section of the Moderna website.Webcast: https://investors.modernatx.comThe archived webcast will be available on...

Read more

Integrative Providers Association (IPA) and Compassion Center Call on U.S. Senate to Fast Track Robert F. Kennedy Jr.’s Confirmation

January 29, 2025 6:30 AM

The Integrative Providers Association (IPA), represents the collective voices of over 14 million integrative healthcare practitioners Nationwide, today announces its strong endorsement of Robert F. Kennedy Jr. for swift confirmation by the U.S. Senate. The IPA firmly believes that those who are standing in the way of Secretary-Designate Kennedy's appointment continue to represent the old guard who continue to push our country further and further...

Read more

NanoViricides to Present at the MicroCap Conference on Wednesday, January 29, 2025

January 29, 2025 6:30 AM

NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), a clinical stage leader developing revolutionary broad-spectrum antiviral drugs that the virus cannot escape, announced that it is presenting today, January 29, at 11am at the MicroCap Conference 2025 in Atlantic City, NJ.Event Information:EventNanoViricides Presentation at the MicroCap Conference, Atlantic CityDay & DateWednesday, January 29, 2025Time11:00 am to 11:30 amLocationThe...

Read more

Platelet Function Test Market Projected Growth to USD 2,607.5 Million with 6.3% CAGR, Driven by Technological Advancements

January 29, 2025 6:00 AM

The global Platelet Function Test Market is set to experience robust growth from 2025 to 2035, with its market size projected to grow from USD 1,375.8 million in 2025 to USD 2,607.5 million by 2035 at a CAGR of 6.3%. This growth is attributed to the increasing prevalence of platelet-related disorders, rising adoption of diagnostic technologies, and growing demand for personalized medicine.The healthcare industry's focus on improving diagnostic...

Read more